These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1506607)

  • 1. A review of cancer cachexia and abnormal glucose metabolism in humans with cancer.
    Tayek JA
    J Am Coll Nutr; 1992 Aug; 11(4):445-56. PubMed ID: 1506607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment.
    Chevalier S; Farsijani S
    Appl Physiol Nutr Metab; 2014 Jun; 39(6):643-53. PubMed ID: 24869969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison.
    Masi T; Patel BM
    Pharmacol Rep; 2021 Feb; 73(1):17-30. PubMed ID: 33141425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis.
    Hardin DS; LeBlanc A; Para L; Seilheimer DK
    Diabetes; 1999 May; 48(5):1082-7. PubMed ID: 10331413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gluconeogenesis in the tumor-influenced rat hepatocyte: importance of tumor burden, lactate, insulin, and glucagon.
    Inculet RI; Peacock JL; Gorschboth CM; Norton JA
    J Natl Cancer Inst; 1987 Nov; 79(5):1039-46. PubMed ID: 3316783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cachexia of malignancy: potential role of insulin in nutritional management.
    Schein PS; Kisner D; Haller D; Blecher M; Hamosh M
    Cancer; 1979 May; 43(5 Suppl):2070-6. PubMed ID: 445387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer cachexia demonstrates the energetic impact of gluconeogenesis in human metabolism.
    Bongaerts GP; van Halteren HK; Verhagen CA; Wagener DJ
    Med Hypotheses; 2006; 67(5):1213-22. PubMed ID: 16797873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal and metabolic abnormalities in the malnourished cancer patient: effects on host-tumor interaction.
    Heber D; Byerley LO; Tchekmedyian NS
    JPEN J Parenter Enteral Nutr; 1992; 16(6 Suppl):60S-64S. PubMed ID: 1287226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic abnormalities in the cancer patient.
    Heber D; Byerly LO; Chlebowski RT
    Cancer; 1985 Jan; 55(1 Suppl):225-9. PubMed ID: 3880655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated gluconeogenesis and lack of suppression by insulin contribute to cystic fibrosis-related diabetes.
    Hardin DS; Ahn C; Rice J; Rice M; Rosenblatt R
    J Investig Med; 2008 Mar; 56(3):567-73. PubMed ID: 18418124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible Involvement of Insulin Resistance in the Progression of Cancer Cachexia in Mice].
    Ohsawa M; Murakami T; Kume K
    Yakugaku Zasshi; 2016; 136(5):687-92. PubMed ID: 27150920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer cachexia and gluconeogenesis.
    Gold J
    Ann N Y Acad Sci; 1974; 230():103-10. PubMed ID: 4522864
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.
    Rossetti L; Giaccari A; Barzilai N; Howard K; Sebel G; Hu M
    J Clin Invest; 1993 Sep; 92(3):1126-34. PubMed ID: 8397219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin action and metabolism in patients with head and neck cancer.
    Byerley LO; Heber D; Bergman RN; Dubria M; Chi J
    Cancer; 1991 Jun; 67(11):2900-6. PubMed ID: 2025856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose metabolism in cachectic patients with colorectal cancer.
    Holroyde CP; Skutches CL; Boden G; Reichard GA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5910-3. PubMed ID: 6388829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of cancer: hormonal and metabolic abnormalities.
    Heber D; Tchekmedyian NS
    Oncology; 1992; 49 Suppl 2():28-31. PubMed ID: 1461623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation and metabolic interconversion in malignant cachexia.
    Waterhouse C
    Cancer Treat Rep; 1981; 65 Suppl 5():61-6. PubMed ID: 7346162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate metabolism in cancer cachexia.
    Holroyde CP; Reichard GA
    Cancer Treat Rep; 1981; 65 Suppl 5():55-9. PubMed ID: 6809325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.